Joyce I Tatelman, MD
General Practice · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 2
Offices
2 locations · Mccloud Healthcare Clinic, Inc. · 10 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Mercy Medical Center Mt Shasta · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tatelman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A60885 · Current
Licensed to practise in California · since 1996 · expires 2028-02-29 · Mcgill University Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Mercy Medical Center of Mt ShastaMount Shasta, CACritical Access Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Mercy Medical Center of Mt Shasta
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 2 better, 2 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 10.7 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 200 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 26 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.3 · 65 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.3 to 16.5) · 450 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.7) · 140 cases | No different | Jan 2024 – Dec 2024 |
What patients said (117 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 86% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 85% |
| Doctors "always" treated them with courtesy and respect | 95% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 85% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 74% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$22,966
Medicare paid this office $22,966 for 123 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 54 | $8,290 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 46 | $7,167 | $156 |
| Short return visit (20+ min) | 26 | $2,092 | $72 |
| Annual depression screening, 5 to 15 minutes | 52 | $1,169 | $22 |
Who their Medicare patients are
123 Original Medicare patients in 2024. Average age 77 · Women 81% · Health risk score 0.86. At or below the middle of the specialty; the typical general practice clinician is at 1.33.
Conditions among them: High blood pressure 59% · Diabetes 20% · Coronary heart disease 19% · Cancer 19% · Atrial fibrillation 17% · Chronic kidney disease 10% · COPD 10% · Depression 10%.
The office billed $63,624, Medicare allowed $28,479 and paid $22,966; for 272 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 123 | 272 | 77 | 0.86 | $63,624 | $22,966 |
| 2023 | 113 | 269 | 77 | 0.98 | $70,914 | $26,839 |
| 2022 | 106 | 248 | 76 | 0.86 | $60,221 | $23,786 |
| 2021 | 114 | 287 | 76 | 0.92 | $51,740 | $27,355 |
| 2020 | 128 | 344 | 77 | 1.07 | $53,160 | $27,357 |
| 2019 | 154 | 510 | 77 | 1.09 | $90,430 | $42,131 |
| 2018 | 157 | 639 | 77 | 0.90 | $123,875 | $52,673 |
| 2017 | 145 | 520 | 76 | 0.83 | $84,545 | $42,070 |
| 2016 | 134 | 420 | 75 | 0.80 | $61,300 | $31,427 |
| 2015 | 131 | 505 | 76 | 0.80 | $64,405 | $33,472 |
| 2014 | 130 | 532 | 76 | 0.81 | $62,815 | $32,646 |
| 2013 | 120 | 460 | 77 | 0.88 | $49,265 | $25,707 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 62 | $10,793 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 46 | $7,035 | $153 |
| Short return visit (20+ min) | 33 | $3,509 | $72 |
2022: 3 services
| Return visit (30+ min) | 62 | $9,725 | $102 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $5,871 | $154 |
| Short return visit (20+ min) | 43 | $3,578 | $70 |
2021: 3 services
| Return visit (30+ min) | 76 | $12,443 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $6,741 | $157 |
| Short return visit (20+ min) | 44 | $4,019 | $73 |
2020: 4 services
| Return visit (30+ min) | 70 | $9,319 | $85 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $8,178 | $139 |
| Short return visit (20+ min) | 54 | $4,279 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $663 | $47 |
2019: 8 services
| Return visit (30+ min) | 111 | $16,848 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $11,729 | $140 |
| Short return visit (20+ min) | 81 | $7,500 | $64 |
| New patient visit (45+ min) | 14 | $1,833 | $131 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 19 | $889 | $47 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 12 | $651 | $54 |
| Administration of influenza virus vaccine | 13 | $267 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $232 | $15 |
2018: 9 services
| Return visit (30+ min) | 123 | $19,380 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 78 | $10,788 | $138 |
| Short return visit (20+ min) | 50 | $3,507 | $57 |
| New patient visit (45+ min) | 20 | $2,838 | $142 |
| Long return visit (40+ min) | 12 | $1,723 | $108 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 27 | $1,412 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 30 | $1,348 | $45 |
| Administration of influenza virus vaccine | 28 | $720 | $26 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $618 | $48 |
2017: 9 services
| Return visit (30+ min) | 111 | $16,178 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 88 | $12,018 | $137 |
| Short return visit (20+ min) | 53 | $3,604 | $52 |
| New patient visit (45+ min) | 19 | $2,255 | $119 |
| Long return visit (40+ min) | 12 | $1,695 | $130 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 30 | $1,373 | $46 |
| Influenza vaccine split virus, preservative free | 21 | $1,003 | $48 |
| Administration of influenza virus vaccine | 23 | $743 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $180 | $13 |
2016: 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 67 | $9,102 | $136 |
| Return visit (30+ min) | 70 | $8,451 | $85 |
| Short return visit (20+ min) | 79 | $5,672 | $52 |
| New patient visit (30+ min) | 20 | $1,311 | $66 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 29 | $1,298 | $45 |
| Influenza vaccine split virus, preservative free | 22 | $877 | $40 |
| Administration of influenza virus vaccine | 23 | $715 | $31 |
2015: 6 services
| Return visit (30+ min) | 70 | $9,844 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $9,007 | $139 |
| Short return visit (20+ min) | 83 | $7,242 | $51 |
| Influenza vaccine split virus, preservative free | 29 | $1,095 | $35 |
| Administration of influenza virus vaccine | 30 | $1,010 | $32 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 15 | $683 | $46 |
2014: 6 services
| Return visit (30+ min) | 75 | $11,682 | $90 |
| Short return visit (20+ min) | 83 | $8,062 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,178 | $135 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 28 | $1,258 | $45 |
| Influenza vaccine split virus, preservative free | 30 | $1,011 | $33 |
| Administration of influenza virus vaccine | 31 | $996 | $31 |
2013: 6 services
| Short return visit (20+ min) | 98 | $11,807 | $59 |
| Return visit (30+ min) | 63 | $7,474 | $91 |
| Influenza vaccine split virus, preservative free | 23 | $740 | $31 |
| Administration of influenza virus vaccine | 14 | $435 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $178 | $15 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 11 | $135 | $12 |
Medicaid work
$11,261 in 2024
Medicaid paid $11,261 for 77 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 77 | $11,261 |
| 2024 | 77 | 1 | 16 | $11,261 |
Drugs they prescribed that Part D paid
$83,610
Pharmacies billed $83,610 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (59 of 1,621) in 2024. Above the middle of the specialty; the typical general practice clinician is at 0%. Long-acting opioids: 20% of their opioid prescriptions.
1,491 generic and fewer than 11 brand-name prescriptions · $83,610 in drug cost · 56 antibiotic prescriptions to 33 people · 28 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xtampza Er | 12 | $14,259 | $1,188 |
| Estradiol | 30 | $3,158 | $105 |
| Synthroid | 18 | $1,529 | $85 |
| Paxlovid | 15 | $1,429 | $95 |
| Atorvastatin | 104 | $921 | $9 |
See all 46 drugs
| Xtampza Er | 12 | $14,259 | $1,188 |
| Estradiol | 30 | $3,158 | $105 |
| Synthroid | 18 | $1,529 | $85 |
| Paxlovid | 15 | $1,429 | $95 |
| Atorvastatin | 104 | $921 | $9 |
| Amlodipine Besylate | 93 | $898 | $10 |
| Levothyroxine | 101 | $851 | $8 |
| Hydrocodone-Acetaminophen | 26 | $819 | $32 |
| Metoprolol | 43 | $747 | $17 |
| Memantine Hcl Er | 13 | $713 | $55 |
| Metformin Hcl Er | 35 | $659 | $19 |
| Losartan | 60 | $633 | $11 |
| Metformin | 47 | $630 | $13 |
| Simvastatin | 47 | $592 | $13 |
| Rosuvastatin | 31 | $587 | $19 |
| Bupropion Xl | 15 | $524 | $35 |
| Pravastatin | 29 | $522 | $18 |
| Donepezil | 36 | $392 | $11 |
| Tamsulosin | 17 | $383 | $23 |
| Sertraline | 44 | $371 | $8 |
| Duloxetine | 18 | $369 | $21 |
| Benazepril | 12 | $322 | $27 |
| Pantoprazole | 22 | $299 | $14 |
| Trazodone | 18 | $272 | $15 |
| Fluticasone Propionate | 13 | $269 | $21 |
| Famotidine | 17 | $254 | $15 |
| Gabapentin | 20 | $247 | $12 |
| Alendronate | 20 | $224 | $11 |
| Lisinopril | 28 | $221 | $8 |
| Ramipril | 15 | $214 | $14 |
| Escitalopram | 24 | $206 | $9 |
| Omeprazole | 14 | $188 | $13 |
| Allopurinol | 14 | $176 | $13 |
| Levetiracetam | 13 | $172 | $13 |
| Hydrochlorothiazide | 24 | $164 | $7 |
| Potassium Chloride | 16 | $150 | $9 |
| Zonisamide | 13 | $138 | $11 |
| Lorazepam | 18 | $117 | $7 |
| Pregabalin | 15 | $112 | $7 |
| Olanzapine | 12 | $91 | $8 |
| Mirtazapine | 15 | $75 | $5 |
| Alprazolam | 11 | $63 | $6 |
| Risperidone | 12 | $46 | $4 |
| Furosemide | 17 | $44 | $3 |
| Tramadol | 14 | $36 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $28 | $2 |
Year by year
| 2024 | 1,621 | 175 | 4% (59) | None | $83,610 |
| 2023 | 1,497 | 162 | 4% (66) | 8% | $81,810 |
| 2022 | 1,303 | 126 | 4% (46) | 12% | $76,502 |
| 2021 | 1,218 | 112 | 3% (30) | None | $78,149 |
| 2020 | 1,396 | 124 | 3% (42) | 12% | $76,944 |
| 2019 | 1,495 | 121 | 3% (40) | None | $93,600 |
| 2018 | 1,564 | 115 | 3% (40) | None | $79,706 |
| 2017 | 1,522 | 105 | 1% (22) | None | $62,050 |
| 2016 | 1,366 | 95 | 2% (21) | None | $66,266 |
| 2015 | 1,398 | 89 | 2% (27) | None | $60,021 |
| 2014 | 1,396 | 92 | 2% (30) | None | $71,390 |
| 2013 | 1,581 | 87 | 3% (39) | None | $95,528 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Memantine Hcl Er | 12 | $1,790 | $149 |
| Hydrocodone-Acetaminophen | 41 | $1,779 | $43 |
| Levothyroxine | 119 | $1,563 | $13 |
| Bupropion Xl | 15 | $1,199 | $80 |
| Amlodipine Besylate | 95 | $1,168 | $12 |
| Losartan | 69 | $1,007 | $15 |
| Atorvastatin | 105 | $963 | $9 |
| Metformin Hcl Er | 28 | $962 | $34 |
| Pregabalin | 17 | $876 | $52 |
| Simvastatin | 47 | $750 | $16 |
| Metoprolol | 34 | $636 | $19 |
| Lisinopril | 36 | $527 | $15 |
| Metformin | 37 | $467 | $13 |
| Pravastatin | 26 | $462 | $18 |
| Sertraline | 38 | $412 | $11 |
| Duloxetine | 23 | $336 | $15 |
| Donepezil | 22 | $325 | $15 |
| Ramipril | 16 | $320 | $20 |
| Gabapentin | 25 | $316 | $13 |
| Levetiracetam | 11 | $304 | $28 |
| Progesterone | 12 | $304 | $25 |
| Losartan-Hydrochlorothiazide | 14 | $282 | $20 |
| Omeprazole | 11 | $281 | $26 |
| Rosuvastatin | 14 | $277 | $20 |
| Risperidone | 12 | $271 | $23 |
| Tamsulosin | 11 | $262 | $24 |
| Famotidine | 11 | $238 | $22 |
| Lorazepam | 23 | $232 | $10 |
| Potassium Chloride | 11 | $220 | $20 |
| Estradiol | 16 | $178 | $11 |
| Paxlovid (Eua) | 16 | $175 | $11 |
| Allopurinol | 11 | $169 | $15 |
| Trazodone | 19 | $157 | $8 |
| Olanzapine | 11 | $136 | $12 |
| Lovastatin | 14 | $96 | $7 |
| Furosemide | 13 | $96 | $7 |
| Hydrochlorothiazide | 15 | $94 | $6 |
| Tramadol | 13 | $44 | $3 |
2022: 32 drugs
| Xarelto | 11 | $5,935 | $540 |
| Memantine Hcl Er | 12 | $2,595 | $216 |
| Levothyroxine | 137 | $1,585 | $12 |
| Losartan | 61 | $909 | $15 |
| Atorvastatin | 97 | $719 | $7 |
| Metformin Hcl Er | 20 | $715 | $36 |
| Hydrocodone-Acetaminophen | 19 | $713 | $38 |
| Bupropion Xl | 15 | $711 | $47 |
| Pregabalin | 15 | $688 | $46 |
| Amlodipine Besylate | 66 | $658 | $10 |
| Metoprolol | 36 | $641 | $18 |
| Simvastatin | 37 | $491 | $13 |
| Pravastatin | 22 | $441 | $20 |
| Acetaminophen-Codeine | 14 | $378 | $27 |
| Metformin | 50 | $375 | $8 |
| Alendronate | 11 | $360 | $33 |
| Fluoxetine | 12 | $351 | $29 |
| Losartan-Hydrochlorothiazide | 16 | $330 | $21 |
| Sertraline | 12 | $288 | $24 |
| Progesterone | 13 | $271 | $21 |
| Omeprazole | 13 | $263 | $20 |
| Gabapentin | 16 | $256 | $16 |
| Lisinopril | 46 | $242 | $5 |
| Risperidone | 12 | $236 | $20 |
| Estradiol | 16 | $182 | $11 |
| Lorazepam | 22 | $165 | $8 |
| Lovastatin | 12 | $120 | $10 |
| Duloxetine | 13 | $107 | $8 |
| Furosemide | 17 | $102 | $6 |
| Zolpidem | 11 | $71 | $6 |
| Hydrochlorothiazide | 16 | $67 | $4 |
| Tramadol | 11 | $27 | $2 |
2021: 29 drugs
| Memantine Hcl Er | 12 | $2,719 | $227 |
| Bupropion Xl | 22 | $2,464 | $112 |
| Levothyroxine | 121 | $2,038 | $17 |
| Synthroid | 15 | $1,609 | $107 |
| Atorvastatin | 101 | $1,393 | $14 |
| Metoprolol | 41 | $981 | $24 |
| Amlodipine Besylate | 66 | $950 | $14 |
| Losartan | 63 | $930 | $15 |
| Pregabalin | 11 | $797 | $72 |
| Metformin Hcl Er | 19 | $607 | $32 |
| Losartan-Hydrochlorothiazide | 17 | $551 | $32 |
| Gabapentin | 17 | $425 | $25 |
| Alendronate | 17 | $394 | $23 |
| Simvastatin | 29 | $388 | $13 |
| Pravastatin | 23 | $382 | $17 |
| Divalproex | 11 | $290 | $26 |
| Lisinopril | 30 | $287 | $10 |
| Famotidine | 13 | $268 | $21 |
| Metformin | 37 | $261 | $7 |
| Acetaminophen-Codeine | 14 | $210 | $15 |
| Omeprazole | 12 | $209 | $17 |
| Lorazepam | 17 | $180 | $11 |
| Sertraline | 11 | $165 | $15 |
| Lovastatin | 12 | $155 | $13 |
| Tamsulosin | 12 | $140 | $12 |
| Tramadol | 11 | $129 | $12 |
| Trazodone | 14 | $90 | $6 |
| Hydrochlorothiazide | 14 | $87 | $6 |
| Duloxetine | 15 | $69 | $5 |
2020: 32 drugs
| Memantine Hcl Er | 11 | $3,444 | $313 |
| Levothyroxine | 125 | $2,665 | $21 |
| Atorvastatin | 94 | $1,438 | $15 |
| Synthroid | 17 | $1,304 | $77 |
| Bupropion Xl | 25 | $985 | $39 |
| Metoprolol | 34 | $939 | $28 |
| Amlodipine Besylate | 84 | $881 | $10 |
| Losartan | 69 | $796 | $12 |
| Simvastatin | 42 | $591 | $14 |
| Pravastatin | 29 | $541 | $19 |
| Losartan-Hydrochlorothiazide | 13 | $501 | $39 |
| Metformin Hcl Er | 14 | $471 | $34 |
| Pantoprazole | 14 | $434 | $31 |
| Gabapentin | 22 | $359 | $16 |
| Omeprazole | 21 | $358 | $17 |
| Metformin | 45 | $330 | $7 |
| Lisinopril | 38 | $329 | $9 |
| Alendronate | 20 | $297 | $15 |
| Acetaminophen-Codeine | 13 | $255 | $20 |
| Famotidine | 20 | $252 | $13 |
| Mirtazapine | 14 | $210 | $15 |
| Tamsulosin | 11 | $208 | $19 |
| Estradiol | 19 | $201 | $11 |
| Levetiracetam | 14 | $194 | $14 |
| Sertraline | 15 | $167 | $11 |
| Hydrochlorothiazide | 27 | $161 | $6 |
| Tramadol | 19 | $148 | $8 |
| Zaleplon | 11 | $118 | $11 |
| Furosemide | 16 | $104 | $7 |
| Lorazepam | 17 | $90 | $5 |
| Lovastatin | 12 | $53 | $4 |
| Alprazolam | 15 | $16 | $1 |
2019: 38 drugs
| Memantine Hcl Er | 12 | $3,638 | $303 |
| Levothyroxine | 133 | $2,529 | $19 |
| Atorvastatin | 75 | $1,259 | $17 |
| Synthroid | 15 | $1,202 | $80 |
| Amlodipine Besylate | 106 | $1,091 | $10 |
| Losartan | 77 | $933 | $12 |
| Sertraline | 25 | $800 | $32 |
| Simvastatin | 49 | $776 | $16 |
| Pantoprazole | 21 | $761 | $36 |
| Metoprolol | 33 | $694 | $21 |
| Pravastatin | 34 | $675 | $20 |
| Ranitidine | 29 | $602 | $21 |
| Metformin Hcl Er | 16 | $523 | $33 |
| Lisinopril | 42 | $508 | $12 |
| Losartan-Hydrochlorothiazide | 18 | $476 | $26 |
| Bupropion Xl | 12 | $473 | $39 |
| Alendronate | 18 | $420 | $23 |
| Donepezil | 18 | $392 | $22 |
| Tramadol | 21 | $374 | $18 |
| Gabapentin | 18 | $330 | $18 |
| Omeprazole | 19 | $317 | $17 |
| Metformin | 35 | $280 | $8 |
| Potassium Chloride | 14 | $273 | $19 |
| Levetiracetam | 24 | $273 | $11 |
| Tamsulosin | 11 | $249 | $23 |
| Benazepril | 11 | $236 | $21 |
| Rabeprazole | 11 | $210 | $19 |
| Furosemide | 18 | $203 | $11 |
| Hydrochlorothiazide | 35 | $163 | $5 |
| Escitalopram | 13 | $135 | $10 |
| Fluoxetine | 11 | $126 | $11 |
| Zaleplon | 11 | $118 | $11 |
| Zolpidem | 16 | $107 | $7 |
| Mirtazapine | 11 | $102 | $9 |
| Acetaminophen-Codeine | 13 | $89 | $7 |
| Lovastatin | 12 | $62 | $5 |
| Citalopram Hbr | 11 | $53 | $5 |
| Alprazolam | 22 | $28 | $1 |
2018: 42 drugs
| Lyrica | 11 | $7,045 | $640 |
| Janumet | 13 | $5,570 | $428 |
| Memantine Hcl Er | 11 | $3,450 | $314 |
| Lantus | 11 | $3,031 | $276 |
| Levothyroxine | 133 | $2,470 | $19 |
| Synthroid | 33 | $1,844 | $56 |
| Atorvastatin | 75 | $1,299 | $17 |
| Amlodipine Besylate | 109 | $936 | $9 |
| Pravastatin | 39 | $872 | $22 |
| Metoprolol | 32 | $861 | $27 |
| Ranitidine | 39 | $681 | $17 |
| Sertraline | 30 | $598 | $20 |
| Midodrine | 12 | $525 | $44 |
| Simvastatin | 40 | $517 | $13 |
| Lisinopril | 63 | $512 | $8 |
| Losartan | 48 | $437 | $9 |
| Pantoprazole | 16 | $424 | $26 |
| Omeprazole | 30 | $397 | $13 |
| Losartan-Hydrochlorothiazide | 18 | $388 | $22 |
| Tramadol | 23 | $376 | $16 |
| Carbidopa-Levodopa | 13 | $374 | $29 |
| Metformin Hcl Er | 18 | $333 | $18 |
| Tamsulosin | 19 | $301 | $16 |
| Benazepril | 26 | $280 | $11 |
| Rabeprazole | 13 | $257 | $20 |
| Baclofen | 12 | $257 | $21 |
| Potassium Chloride | 13 | $257 | $20 |
| Donepezil | 12 | $247 | $21 |
| Metformin | 25 | $227 | $9 |
| Alendronate | 29 | $192 | $7 |
| Fluoxetine | 12 | $191 | $16 |
| Hydrochlorothiazide | 28 | $177 | $6 |
| Lactulose | 11 | $156 | $14 |
| Atenolol | 16 | $149 | $9 |
| Levetiracetam | 11 | $146 | $13 |
| Fluticasone Propionate | 12 | $140 | $12 |
| Zaleplon | 12 | $134 | $11 |
| Allopurinol | 14 | $131 | $9 |
| Zolpidem | 15 | $114 | $8 |
| Lovastatin | 14 | $92 | $7 |
| Alprazolam | 36 | $90 | $2 |
| Acyclovir | 14 | $77 | $6 |
2017: 35 drugs
| Lyrica | 14 | $5,084 | $363 |
| Janumet | 13 | $5,053 | $389 |
| Levothyroxine | 116 | $2,468 | $21 |
| Entacapone | 12 | $1,841 | $153 |
| Synthroid | 38 | $1,779 | $47 |
| Atorvastatin | 81 | $1,578 | $19 |
| Metoprolol | 36 | $1,548 | $43 |
| Amlodipine Besylate | 140 | $978 | $7 |
| Losartan | 65 | $571 | $9 |
| Midodrine | 13 | $544 | $42 |
| Simvastatin | 46 | $527 | $11 |
| Sertraline | 24 | $519 | $22 |
| Ranitidine | 42 | $462 | $11 |
| Lisinopril | 59 | $453 | $8 |
| Carbidopa-Levodopa | 16 | $449 | $28 |
| Omeprazole | 41 | $377 | $9 |
| Losartan-Hydrochlorothiazide | 19 | $364 | $19 |
| Hydrochlorothiazide | 47 | $351 | $7 |
| Baclofen | 18 | $290 | $16 |
| Pantoprazole | 11 | $287 | $26 |
| Benazepril | 27 | $259 | $10 |
| Tamsulosin | 17 | $247 | $15 |
| Zolpidem | 25 | $225 | $9 |
| Rabeprazole | 12 | $221 | $18 |
| Metformin Hcl Er | 18 | $219 | $12 |
| Tramadol | 15 | $196 | $13 |
| Pravastatin | 13 | $189 | $15 |
| Polyethylene Glycol 3350 | 17 | $183 | $11 |
| Atenolol | 26 | $163 | $6 |
| Fluticasone Propionate | 14 | $159 | $11 |
| Metformin | 14 | $145 | $10 |
| Lovastatin | 15 | $143 | $10 |
| Alendronate | 26 | $134 | $5 |
| Norgestimate-Ethinyl Estradiol | 11 | $126 | $11 |
| Alprazolam | 31 | $63 | $2 |
2016: 34 drugs
| Onglyza | 13 | $4,803 | $369 |
| Crestor | 13 | $4,636 | $357 |
| Janumet | 12 | $4,375 | $365 |
| Levothyroxine | 97 | $2,187 | $23 |
| Lyrica | 12 | $2,011 | $168 |
| Bystolic | 12 | $1,504 | $125 |
| Synthroid | 35 | $1,494 | $43 |
| Amlodipine Besylate | 133 | $1,028 | $8 |
| Atorvastatin | 57 | $1,025 | $18 |
| Metoprolol | 13 | $644 | $50 |
| Sertraline | 28 | $588 | $21 |
| Lisinopril | 67 | $536 | $8 |
| Omeprazole | 43 | $534 | $12 |
| Simvastatin | 41 | $532 | $13 |
| Losartan | 39 | $498 | $13 |
| Hydrochlorothiazide | 53 | $447 | $8 |
| Ibandronate | 12 | $441 | $37 |
| Ramipril | 13 | $429 | $33 |
| Oxazepam | 11 | $415 | $38 |
| Pravastatin | 13 | $377 | $29 |
| Fluticasone Propionate | 18 | $308 | $17 |
| Pantoprazole | 18 | $300 | $17 |
| Zolpidem | 26 | $290 | $11 |
| Metformin | 32 | $271 | $8 |
| Necon | 13 | $250 | $19 |
| Losartan-Hydrochlorothiazide | 13 | $226 | $17 |
| Duloxetine | 11 | $207 | $19 |
| Allopurinol | 16 | $179 | $11 |
| Ranitidine | 22 | $176 | $8 |
| Benazepril | 20 | $151 | $8 |
| Atenolol | 32 | $133 | $4 |
| Tramadol | 12 | $123 | $10 |
| Alprazolam | 22 | $76 | $3 |
| Alendronate | 13 | $41 | $3 |
2015: 34 drugs
| Vesicare | 12 | $2,737 | $228 |
| Lyrica | 12 | $1,939 | $162 |
| Levothyroxine | 84 | $1,721 | $20 |
| Atorvastatin | 63 | $1,186 | $19 |
| Synthroid | 29 | $1,179 | $41 |
| Amlodipine Besylate | 131 | $1,071 | $8 |
| Metoprolol | 16 | $895 | $56 |
| Amlodipine Besylate-Benazepril | 14 | $688 | $49 |
| Omeprazole | 39 | $616 | $16 |
| Simvastatin | 60 | $584 | $10 |
| Sertraline | 24 | $572 | $24 |
| Duloxetine | 12 | $513 | $43 |
| Losartan | 49 | $491 | $10 |
| Hydrochlorothiazide | 42 | $435 | $10 |
| Lisinopril | 62 | $426 | $7 |
| Estradiol | 15 | $396 | $26 |
| Fluticasone Propionate | 30 | $275 | $9 |
| Losartan-Hydrochlorothiazide | 18 | $262 | $15 |
| Potassium Chloride | 11 | $252 | $23 |
| Metformin | 34 | $240 | $7 |
| Necon | 12 | $230 | $19 |
| Zolpidem | 20 | $195 | $10 |
| Clopidogrel | 14 | $190 | $14 |
| Metformin Hcl Er | 11 | $139 | $13 |
| Alendronate | 26 | $133 | $5 |
| Escitalopram | 16 | $132 | $8 |
| Carvedilol | 16 | $131 | $8 |
| Atenolol | 30 | $127 | $4 |
| Allopurinol | 17 | $120 | $7 |
| Benazepril | 21 | $115 | $5 |
| Lactulose | 12 | $111 | $9 |
| Ranitidine | 12 | $88 | $7 |
| Famotidine | 12 | $83 | $7 |
| Alprazolam | 13 | $82 | $6 |
2014: 43 drugs
| Januvia | 15 | $6,720 | $448 |
| Diovan | 12 | $3,410 | $284 |
| Nexium | 13 | $3,219 | $248 |
| Myrbetriq | 12 | $2,474 | $206 |
| Amlodipine Besylate-Benazepril | 18 | $1,950 | $108 |
| Levothyroxine | 85 | $1,597 | $19 |
| Duloxetine | 12 | $1,588 | $132 |
| Metoprolol | 20 | $1,383 | $69 |
| Pioglitazone | 16 | $1,309 | $82 |
| Amlodipine Besylate | 121 | $1,164 | $10 |
| Atorvastatin | 59 | $1,119 | $19 |
| Synthroid | 25 | $939 | $38 |
| Losartan | 43 | $723 | $17 |
| Sertraline | 28 | $717 | $26 |
| Omeprazole | 38 | $661 | $17 |
| Simvastatin | 53 | $653 | $12 |
| Proair Hfa | 12 | $587 | $49 |
| Donepezil | 14 | $492 | $35 |
| Potassium Chloride | 15 | $466 | $31 |
| Lisinopril | 49 | $398 | $8 |
| Oxazepam | 11 | $390 | $35 |
| Hydrochlorothiazide | 38 | $333 | $9 |
| Metformin | 31 | $319 | $10 |
| Fluticasone Propionate | 20 | $319 | $16 |
| Estradiol | 12 | $317 | $26 |
| Hydrocodone-Acetaminophen | 15 | $306 | $20 |
| Escitalopram | 11 | $297 | $27 |
| Losartan-Hydrochlorothiazide | 15 | $288 | $19 |
| Clopidogrel | 17 | $266 | $16 |
| Necon | 12 | $230 | $19 |
| Atenolol | 28 | $213 | $8 |
| Pantoprazole | 24 | $209 | $9 |
| Carvedilol | 23 | $193 | $8 |
| Meloxicam | 11 | $171 | $16 |
| Trazodone | 14 | $124 | $9 |
| Metoprolol | 11 | $120 | $11 |
| Alendronate | 17 | $115 | $7 |
| Azithromycin | 14 | $109 | $8 |
| Allopurinol | 11 | $99 | $9 |
| Famotidine | 13 | $86 | $7 |
| Alprazolam | 14 | $83 | $6 |
| Benazepril | 13 | $77 | $6 |
| Chlorhexidine Gluconate | 12 | $73 | $6 |
2013: 43 drugs
| Namenda | 24 | $6,280 | $262 |
| Aciphex | 19 | $6,033 | $318 |
| Januvia | 16 | $5,538 | $346 |
| Nexium | 17 | $5,308 | $312 |
| Diovan | 30 | $5,091 | $170 |
| Colcrys | 15 | $3,073 | $205 |
| Benicar | 19 | $2,650 | $139 |
| Atorvastatin | 51 | $2,239 | $44 |
| Pioglitazone | 15 | $1,772 | $118 |
| Amlodipine Besylate-Benazepril | 18 | $1,696 | $94 |
| Amlodipine Besylate | 135 | $1,450 | $11 |
| Levothyroxine | 86 | $1,135 | $13 |
| Metoprolol | 17 | $1,100 | $65 |
| Losartan | 47 | $932 | $20 |
| Synthroid | 25 | $895 | $36 |
| Sertraline | 41 | $859 | $21 |
| Simvastatin | 62 | $848 | $14 |
| Omeprazole | 27 | $754 | $28 |
| Irbesartan | 16 | $736 | $46 |
| Metformin | 49 | $717 | $15 |
| Lisinopril | 63 | $624 | $10 |
| Estradiol | 24 | $599 | $25 |
| Isosorbide Dinitrate | 12 | $523 | $44 |
| Clopidogrel | 21 | $460 | $22 |
| Hydrochlorothiazide | 45 | $419 | $9 |
| Donepezil | 19 | $374 | $20 |
| Fluticasone Propionate | 16 | $354 | $22 |
| Atenolol | 21 | $333 | $16 |
| Lovastatin | 29 | $291 | $10 |
| Losartan-Hydrochlorothiazide | 12 | $277 | $23 |
| Hydrocodone-Acetaminophen | 22 | $254 | $12 |
| Tramadol | 11 | $243 | $22 |
| Alendronate | 15 | $235 | $16 |
| Necon | 12 | $228 | $19 |
| Lisinopril-Hydrochlorothiazide | 18 | $217 | $12 |
| Carvedilol | 22 | $203 | $9 |
| Trazodone | 24 | $171 | $7 |
| Metoprolol | 20 | $155 | $8 |
| Meloxicam | 11 | $144 | $13 |
| Lorazepam | 11 | $112 | $10 |
| Allopurinol | 18 | $104 | $6 |
| Famotidine | 16 | $93 | $6 |
| Alprazolam | 12 | $54 | $5 |
Money from drug and device companies
$48 in 2025
| 2025 | 2 | 2 | None | $48 |
| 2024 | 1 | 1 | None | $20 |
| 2023 | 2 | 3 | None | $68 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $26 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $22 | 1 payment
|
See all 2 published payments
| Dexcom | Meals · 2025-10-28 | Dexcom G6 Transmitter | $26 |
| Exact Sciences | Meals · 2025-03-20 | Cologuard Collection Kit | $22 |
See earlier years (2024, 2023, 2019)
2024: $20
| Pfizer | Paxlovid | $20 | 1 payment
|
2023: $68
| GlaxoSmithKline | Arexvy | $47 | 2 payments
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $21 | 1 payment
|
2019: $20
| Medline Industries | None | $20 | 1 payment
|
Professional record
- NPI
- 1447276878
- Licence
- CA A60885California A60885: Current · expires 2028-02-29
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2204 Grant Rd, Suite 202, Mountain View, CA, 94040
- NPI first listed
- 2006-07-15
- NPI last updated
- 2024-08-14
- NPI record certified
- 2024-08-14
This is when the NPI record was last certified, not a medical board exam.